Pancreatic cancer test kit CA19-9

for clinical chemistryoncologyfor home use

Overview
Carbohydrate Antigen 19-9 (CA19-9) Test Kit is an in vitro homogeneous chemiluminescence immunoassay for the quantitative determination of CA19-9 in human serum and plasma. The kit is intended as an aid in the diagnosis of pancreatic cancer and is for professional laboratory use only.

Measurement principle
Chemiluminescence Resonance Energy Transfer (CRET).

Key features

• Rapid quantitative assay: results in approximately 5 minutes.
• Lyophilized bead formulation suitable for variable transport conditions.
• Individual reagent packaging to minimize waste.
• Extended shelf life at room temperature (no cold chain required).
• Simple operation compatible with point-of-care (POCT) workflows.

Application scenarios

• Home-use screening scenarios
• Emergency care
• Outpatient departments
• Clinical laboratories
• Hospital clinical departments
• Ambulance and mobile testing

Technical specifications

• Product name: Carbohydrate Antigen 19-9 (CA19-9) Test Kit (Homogeneous Chemiluminescence Immunoassay)
• Specification: 25 Tests/Box
• Sample type: Serum, plasma
• Applicable instrument: Chemiluminescence Immunoassay Analyzer (C5000)
• Result time: 5 min
• Shelf life: 18 months
• Storage: 2 - 30°C, away from sunlight (no cold chain)
• Certifications: CE, NMPA
• Measurement principle: Chemiluminescence Resonance Energy Transfer (CRET)